Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · IEX Real-Time Price · USD
31.43
-0.10 (-0.32%)
Jul 26, 2024, 4:00 PM EDT - Market closed
IART Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for IART stock have an average target of 34.88, with a low estimate of 25 and a high estimate of 50. The average target predicts an increase of 10.98% from the current stock price of 31.43.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for IART stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 3 | 4 | 4 | 3 |
| Sell | 2 | 2 | 2 | 3 | 3 | 2 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 11 | 11 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $25 → $32 | Hold | Maintains | $25 → $32 | +1.81% | Jul 16, 2024 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $24 → $27 | Sell | Maintains | $24 → $27 | -14.09% | Jul 15, 2024 |
| Citigroup | Citigroup | Hold Maintains $28 → $30 | Hold | Maintains | $28 → $30 | -4.55% | Jul 10, 2024 |
| Citigroup | Citigroup | Hold Maintains $24 → $28 | Hold | Maintains | $24 → $28 | -10.91% | May 22, 2024 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $37 → $24 | Sell | Maintains | $37 → $24 | -23.64% | May 7, 2024 |
Financial Forecast
Revenue This Year
1.71B
from 1.54B
Increased by 10.86%
Revenue Next Year
1.81B
from 1.71B
Increased by 5.73%
EPS This Year
3.10
from 0.84
Increased by 268.56%
EPS Next Year
3.39
from 3.10
Increased by 9.39%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.8B | 1.9B | 2.0B |
| Avg | 1.7B | 1.8B | 1.9B |
| Low | 1.6B | 1.7B | 1.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 14.4% | 10.5% | 9.9% |
| Avg | 10.9% | 5.7% | 4.6% |
| Low | 6.3% | 0.9% | -0.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.24 | 3.70 | 4.00 |
| Avg | 3.10 | 3.39 | 3.76 |
| Low | 2.94 | 2.98 | 3.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 286.0% | 19.4% | 18.2% |
| Avg | 268.6% | 9.4% | 11.1% |
| Low | 250.0% | -3.8% | -8.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.